young healthy subjects.
Conditions
Interventions
Intervention 1: Intervention group: At the beginning of the intervention, each participant is given a pack with a three-digit code that contains 250 mg Ginger capsules or placebo, then every half an h
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
19 Years to 26 Years
Inclusion criteria
Inclusion criteria: Healthy subjects Normal Body Mass Index (BMI) 19 to 26 years old
Exclusion criteria
Exclusion criteria: Smoking Alcohol consumption Substance abuse Cardiovascular diseases Acute and chronic diseases Prohibition of Ginger
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of Ginger 250 mg capsules on HRV. Timepoint: Before starting the intervention and every 30 minutes after the start of taking Ginger 250 mg capsules or placebo for 4 hours. Method of measurement: HRV recording device and eprobe software. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Iraj Jafaripour
Babol University of Medical Sciences
Outcome results
None listed